V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002124 | 210005736 | 1.64 | 59.8 | Adjuvant (A) | null | 2017-02-22 | TRASTUZUMAB | null | N | TRASTUZUMAB | 100779863 |
| 210002126 | 210005737 | 1.71 | 55.9 | Adjuvant (A) | 2017-01-04 | 2017-01-23 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100667715 |
| 210002127 | 210005738 | 1.59 | 59 | 02 | null | 2018-10-01 | Docetaxel | null | N | DOCETAXEL | 100657281 |
| 210002128 | 210005739 | 1.54 | 48.9 | Neo-adjuvant (N) | 2017-06-11 | 2017-06-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101053468 |
| 210002129 | 210005740 | 1.52 | 76.95 | Neo-adjuvant (N) | 2018-08-04 | 2018-08-21 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100344583 |
| 210002130 | 210005741 | 1.62 | 69.3 | Adjuvant (A) | 2018-12-14 | 2018-12-31 | Paclitaxel 7 day | null | N | PACLITAXEL | 101230315 |
| 210002131 | 210005742 | null | null | Adjuvant (A) | 2015-07-09 | 2016-11-20 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100858252 |
| 210002135 | 210005743 | 1.68 | 52.9 | Adjuvant (A) | null | 2020-01-16 | Trastuzumab Subcutaneous | 2 | N | TRASTUZUMAB | 101160467 |
| 210002140 | 210005747 | 1.6 | 66.25 | null | null | 2018-06-26 | PACLITAXEL | null | N | PACLITAXEL | 100755361 |
| 210002141 | 210005748 | 1.71 | 79 | null | 2017-01-31 | 2017-02-02 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101826746 |
| 210002142 | 210005749 | 1.7 | 62 | Adjuvant (A) | 2016-12-03 | 2016-12-11 | Paclitaxel 7 day | null | N | PACLITAXEL | 100153566 |
| 210002143 | 210005750 | 1.65 | 60.3 | Adjuvant (A) | 2019-01-26 | 2019-01-26 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101591450 |
| 210002144 | 210005751 | 1.64 | 58 | Palliative (P) | 2018-09-30 | 2018-11-28 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100163344 |
| 210002146 | 210005752 | 1.62 | 93 | Palliative (P) | 2018-08-26 | 2018-09-21 | Docetaxel | 02 | null | DOCETAXEL | 101460438 |
| 210002149 | 210005754 | null | null | null | null | 2017-08-28 | Docetaxel | null | null | DOCETAXEL | 101556834 |
| 210002150 | 210005755 | 1.61 | 65 | Adjuvant (A) | 2018-09-24 | 2018-10-02 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100124746 |
| 210002152 | 210005757 | 1.61 | 85.7 | Adjuvant (A) | 2018-09-26 | 2018-12-20 | Docetaxel | 02 | N | DOCETAXEL | 101833420 |
| 210002153 | 210005758 | 1.68 | 73.6 | Palliative (P) | null | 2017-09-28 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100474839 |
| 210002154 | 210005759 | 1.71 | 71.5 | Neo-adjuvant (N) | null | 2016-09-02 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100827829 |
| 210002155 | 210005760 | 1.71 | 70.8 | Neo-adjuvant (N) | 2019-02-25 | 2019-06-18 | EC | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100790697 |
| 210002156 | 210005761 | 1.52 | 106.8 | Adjuvant (A) | null | 2017-07-31 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100527491 |
| 210002157 | 210005762 | 1.53 | 91.7 | Neo-adjuvant (N) | null | 2018-04-30 | PACLITAXEL | N | N | PACLITAXEL | 100097238 |
| 210002158 | 210005763 | 1.54 | 49 | null | 2019-09-08 | 2019-10-06 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101126136 |
| 210002162 | 210005765 | 1.6 | 61.7 | Adjuvant (A) | 2018-06-28 | 2018-07-21 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101511780 |
| 210002163 | 210005766 | 1.54 | 86.9 | Neo-adjuvant (N) | null | 2018-07-09 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 100828560 |
| 210002164 | 210005767 | 1.58 | 103 | Adjuvant (A) | 2018-08-13 | 2018-08-21 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101609360 |
| 210002165 | 210005768 | null | 60.3 | Adjuvant (A) | 2016-08-25 | 2016-09-11 | CYCLOPHOSPHAMIDE + EPIRUBICIN | N | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101108887 |
| 210002167 | 210005769 | 1.6 | 63.95 | Adjuvant (A) | 2017-02-20 | 2017-03-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100450806 |
| 210002168 | 210005770 | 1.57 | 55.7 | Adjuvant (A) | 2016-11-01 | 2016-11-14 | TRASTUZUMAB | null | N | TRASTUZUMAB | 101002461 |
| 210002169 | 210005771 | 1.59 | 88.1 | Adjuvant (A) | 2020-01-12 | 2020-01-27 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100533630 |
| 210002172 | 210005773 | 1.44 | 50.4 | Neo-adjuvant (N) | null | 2017-12-02 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100560671 |
| 210002174 | 210005774 | 1.51 | 63.1 | Adjuvant (A) | 2017-04-07 | 2017-04-15 | TRASTUZUMAB | 02 | N | TRASTUZUMAB | 100944998 |
| 210002175 | 210005775 | 1.55 | 74 | Adjuvant (A) | 2017-04-05 | 2017-08-17 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100388905 |
| 210002177 | 210005777 | null | null | Adjuvant (A) | 2016-10-23 | 2016-11-04 | Trastuzumab | 02 | N | TRASTUZUMAB | 101503833 |
| 210002178 | 210005778 | 1.55 | 72.3 | Adjuvant (A) | 2018-11-07 | 2018-11-09 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101532564 |
| 210002180 | 210005779 | 1.68 | 66.25 | null | 2017-01-03 | 2017-01-23 | Trastuzumab | 02 | null | TRASTUZUMAB | 101812162 |
| 210002184 | 210005782 | 1.6 | 54.7 | Adjuvant (A) | 2018-10-15 | 2018-10-22 | Docetaxel | 02 | N | DOCETAXEL | 100443007 |
| 210002185 | 210005783 | 1.76 | 65.3 | Palliative (P) | 2016-04-20 | 2016-08-09 | Trastuzumab | 02 | N | TRASTUZUMAB | 101288944 |
| 210002186 | 210005784 | 1.56 | 116.1 | Neo-adjuvant (N) | 2019-02-19 | 2019-05-07 | Docetaxel | null | N | DOCETAXEL | 101496677 |
| 210002187 | 210005785 | 1.66 | 62.4 | Palliative (P) | null | 2016-08-23 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100468124 |
| 210002188 | 210005786 | 1.61 | 69.5 | Adjuvant (A) | 2018-04-20 | 2018-06-16 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100906620 |
| 210002189 | 210005787 | null | 71 | Adjuvant (A) | null | 2018-09-28 | Docetaxel | 02 | N | DOCETAXEL | 100656573 |
| 210002192 | 210005789 | 1.55 | 74 | Adjuvant (A) | 2017-02-28 | 2017-02-28 | Docetaxel | 02 | N | DOCETAXEL | 101479248 |
| 210002194 | 210005790 | 1.65 | 85.3 | Adjuvant (A) | 2019-05-05 | 2019-07-15 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100630436 |
| 210002197 | 210005793 | 1.54 | 84.7 | Adjuvant (A) | 2017-07-20 | 2017-08-08 | Paclitaxel 7 day | null | N | PACLITAXEL | 101166836 |
| 210002198 | 210005794 | 1.55 | 92.5 | Adjuvant (A) | 2016-08-26 | 2016-09-17 | Docetaxel | 01 | N | DOCETAXEL | 100729379 |
| 210002199 | 210005795 | 1.63 | 70 | Neo-adjuvant (N) | 2018-04-11 | 2018-07-11 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100074046 |
| 210002201 | 210005797 | 1.59 | 89.6 | Neo-adjuvant (N) | 2020-05-20 | 2020-06-03 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 101167766 |
| 210002204 | 210005800 | 0 | 52 | Adjuvant (A) | 2019-12-05 | 2020-02-13 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101677789 |
| 210002206 | 210005802 | 1.63 | 45.6 | Neo-adjuvant (N) | 2016-04-03 | 2016-04-13 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100923093 |